# Sonexa Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sonexa-therapeutics

- Industry: Pharmaceuticals
- Headquarters: San Diego, US
- Website: www.sonexa.com
- Total disclosed funding: $30M
- Latest round: Series A (Jan 31, 2008)
- Investors on record: 5

## About

Founded in 2007 and California, US, Sonexa Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops drug treatments and therapeutics for Alzheimer's disease and related disorders. The company's product ST101, an active molecule compound which is small and orally taken, penetrates through the blood-brain-barrier and restores learning and memory capability throughout animal models of cognitive impairment relevant to Alzheimer's.

## Funding rounds

- Series A, Jan 31, 2008, $30M — Alta Partners, Domain Associates, Scale Venture Partners, GeneChem, Mitsubishi Corporation

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series A
- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series A
- Scale Venture Partners (https://capitalatlas.ai/funds/scale-venture-partners) — Series A
- GeneChem (https://capitalatlas.ai/funds/genechem) — Series A
- Mitsubishi Corporation — Series A